Showing results (781-790 of 797) with videos related to
Sort By:
Pageof 80
Journal of the European Academy of Dermatology and Venereology : JEADV|August 18, 2022
European guideline (EuroGuiDerm) on atopic eczema: part I - systemic therapyA Wollenberg, M Kinberger, B Arents, et al.Nature Genetics|August 10, 2000
Genome-wide, large-scale production of mutant mice by ENU mutagenesisM H Hrabé de Angelis, H Flaswinkel, H Fuchs, et al.Allergy|May 5, 2016
Drug allergy passport and other documentation for patients with drug hypersensitivity - An ENDA/EAACI Drug Allergy Interest Group Position PaperK Brockow, W Aberer, M Atanaskovic-Markovic, et al.Allergy|April 28, 2009
GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'J Bousquet, P G Burney, T Zuberbier, et al.Allergy|January 31, 2009
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda projectP-J Bousquet, P Demoly, A Romano, et al.Allergy|November 5, 2011
Practical guide to skin prick tests in allergy to aeroallergensJ Bousquet, L Heinzerling, C Bachert, et al.Medrxiv : the Preprint Server for Health Sciences|July 20, 2021
Genetic regulation of OAS1 nonsense-mediated decay underlies association with risk of severe COVID-19A Rouf Banday, Megan L Stanifer, Oscar Florez-Vargas, et al.International Archives of Allergy and Immunology|March 3, 2012
Severe chronic allergic (and related) diseases: a uniform approach--a MeDALL--GA2LEN--ARIA position paper, J Bousquet, J M Anto, et al.Allergologie Select|November 8, 2018
Food-induced anaphylaxis and cofactors - data from the anaphylaxis registryM Worm, K Scherer, A Köhli-Wiesner, et al.Nature Genetics|July 14, 2022
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestriesA Rouf Banday, Megan L Stanifer, Oscar Florez-Vargas, et al.Pageof 80